These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8423959)

  • 1. Systematic serologic screening for toxoplasmosis in pregnancy.
    Roos T; Martius J; Gross U; Schrod L
    Obstet Gynecol; 1993 Feb; 81(2):243-50. PubMed ID: 8423959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].
    Binquet C; Wallon M; Quantin C; Gadreau M; Peyron F
    Rev Epidemiol Sante Publique; 2002 Oct; 50(5):475-87. PubMed ID: 12471340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study.
    Singh S; Pandit AJ
    Am J Reprod Immunol; 2004 Oct; 52(4):276-83. PubMed ID: 15494049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis].
    Paul M
    Wiad Parazytol; 1997; 43(1):39-51. PubMed ID: 9289926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women.
    Candolfi E; Pastor R; Huber R; Filisetti D; Villard O
    Diagn Microbiol Infect Dis; 2007 May; 58(1):83-8. PubMed ID: 17368807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxoplasmosis diagnosis in pregnancy: computer assisted follow-up interpretation of serologic tests].
    Nagy S; Hayde M; Panzenböck B; Adlassnig KP; Pollak A
    Wien Klin Wochenschr; 1997 Sep; 109(16):641-6. PubMed ID: 9412085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of immunoglobulin M(IgM)-immunosorbent agglutination assay (ISAGA) for diagnosis of toxoplasmosis.
    Zhang S; Wei M; Zhao H; Shi G
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(4):225-7. PubMed ID: 12563770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasmosis surveillance during pregnancy and quality assurance of methods in Hungary.
    Szénási Z; Horváth K; Sárkány E; Melles M
    Wien Klin Wochenschr; 2005; 117 Suppl 4():29-34. PubMed ID: 16416382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commercial laboratory IgM testing for Toxoplasma gondii in pregnancy: a 20-year experience.
    Garry DJ; Elimian A; Wiencek V; Baker DA
    Infect Dis Obstet Gynecol; 2005 Sep; 13(3):151-3. PubMed ID: 16126500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update on toxoplasmosis prevalence based on serological tests in pregnant women in Dakar, Senegal from 2002 to 2006].
    Ndiaye D; Sène PD; Ndiaye M; Faye B; Ndiaye JL; Ndir O
    Med Trop (Mars); 2011 Feb; 71(1):101-2. PubMed ID: 21585110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost analysis of toxoplasma infection control in pregnancy].
    Charrier L; Moiraghi Ruggenini A; Renga G; Ditommaso S; Lievre MA; Zotti C
    Ann Ig; 2003; 15(5):505-14. PubMed ID: 14969303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].
    Piergili Fioretti D
    Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neonatal screening of congenital toxoplasmosis. Prospective study].
    Ben Hamida Nouaïli E; Chaouachi S; Meftah N; Bardi R; Sfar R; Marrakchi Z
    Tunis Med; 2009 Mar; 87(3):196-9. PubMed ID: 19537013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis.
    Tanyuksel M; Guney C; Araz E; Saracli MA; Doganci L
    J Microbiol; 2004 Sep; 42(3):211-5. PubMed ID: 15459650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasmosis: prevalence and risk factors.
    Nissapatorn V; Noor Azmi MA; Cho SM; Fong MY; Init I; Rohela M; Khairul Anuar A; Quek KF; Latt HM
    J Obstet Gynaecol; 2003 Nov; 23(6):618-24. PubMed ID: 14617462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasmosis: the innocent suspect of pregnancy wastage in Duhok, Iraq.
    Razzak AH; Wais SA; Saeid AY
    East Mediterr Health J; 2005 Jul; 11(4):625-32. PubMed ID: 16700377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mother-child pass in Austria and primary toxoplasmosis infections in pregnant women.
    Moese JR; Vander-Moese A
    Cent Eur J Public Health; 1998 Nov; 6(4):261-4. PubMed ID: 9919373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasmosis screening and risk factors amongst pregnant females in Natal, northeastern Brazil.
    Barbosa IR; de Carvalho Xavier Holanda CM; de Andrade-Neto VF
    Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):377-82. PubMed ID: 19211119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxoplasmosis-antibody seroprevalence in Mecklenburg-Western Pomerania].
    Fiedler K; Hülsse C; Straube W; Briese V
    Zentralbl Gynakol; 1999; 121(5):239-43. PubMed ID: 10408076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery.
    Lago EG; Neto EC; Melamed J; Rucks AP; Presotto C; Coelho JC; Parise C; Vargas PR; Goldbeck AS; Fiori RM
    Paediatr Perinat Epidemiol; 2007 Nov; 21(6):525-31. PubMed ID: 17937738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.